Answers are grounded in this paper and cite their sources.
Colectomy • Conversion • NeoplasiaDeveloped in the 1980s and 2000s respectively, laparoscopic and robotic colectomies are two minimally invasive surgical approaches that offer benefits in treatment of colon cancers, including lower morbidity and shorter hospital stays, compared to their laparotomy counterparts [1][2][3][4][5][6].Robotic approaches were initially developed to address certain limitations of laparoscopic approaches, specifically improving three dimensional vision, dexterity, and stabilization of tremors, and in colorectal surgery proved to have lower conversion rates but longer operating time and higher costs [7][8][9][10][11][12].The conversion rates for laparoscopic colectomies and robotic colectomies are reported between 5.2 and 16.6% or 4.1-7.4%,respectively, favoring robotic surgery [13][14][15][16][17][18][19].Converted minimally-invasive operations are associated with worse outcomes.For both laparoscopic converted to open (LCTO) and robotic converted to open (RCTO) colectomies, patients experience higher blood loss, longer mean hospital stays, and higher complication rates as well as higher costs [13,[15][16][17]19].Though there are many studies comparing robotic and laparoscopic colectomies, comparisons between converted minimally invasive surgeries are lacking.This study aimed to use a large national database, the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database, to compare patient characteristics and short term outcomes following converted laparoscopic and converted robotic colectomies for colon cancers from 2012 to 2020. Methods and proceduresColectomy datasets from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database was retrospectively queried for patients who underwent elective LCTO and RCTO colectomies for colon cancers between 2012 and 2020.The database describes conversions from either platform as unplanned, but does not provide any further specifications as to size of incision or reason for conversion.Cases involving only colon cancers were selected using International Classification of Diseases Revision Ninth/ Tenth (ICD-9/10) codes.These included all codes related to malignant neoplasms of the colon: 153.0, 153.1, 153.2, 153.3, 153.4,153.5, 153.6, 153.7, 153.8, and 153.9, or C18.0, C18.1, C18.2, C18.3, C18.4,C18.5, C18.6 and C18.7.Patients who had completely dependent functional health status, American Society of Anesthesiologists (ASA) classification IV or higher, preoperative sepsis, disseminated cancer, and those with missing demographic data points were excluded.Pre-operative characteristics as well as intraoperative and postoperative outcomes for the two groups were identified.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: